BIOMARIN PHARMACEUTICAL INC Cost of Revenue
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Cost of Revenue of $202.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC cost of revenue for the quarter ending 2026-06-30 was $202.79M, a 35.12% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC cost of revenue for the quarter ending 2026-03-31 was $195.00M, a 28.66% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC cost of revenue for the quarter ending 2025-12-31 was $275.71M, a 102.52% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC cost of revenue for the quarter ending 2025-09-30 was $140.09M, a 25.67% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC cost of revenue for fiscal 2025 was $717.44M, a 23.65% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC cost of revenue for fiscal 2024 was $580.24M, a 9.05% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC cost of revenue for fiscal 2023 was $532.06M, a 5.77% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC cost of revenue for fiscal 2022 was $503.02M, a 6.91% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $202.79M 10-Q · filed 2026-08-06 | $397.79M 10-Q · filed 2026-08-06 | $673.50M derived: sum of 3 quarters · filed 2026-08-06 | $813.59M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $195.00M 10-Q · filed 2026-05-05 | $470.71M derived: sum of 2 quarters · filed 2026-05-05 | $610.79M derived: sum of 3 quarters · filed 2026-05-05 | $760.88M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $275.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $415.79M derived: sum of 2 quarters · filed 2026-02-26 | $565.88M derived: sum of 3 quarters · filed 2026-08-06 | $717.44M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $140.09M 10-Q · filed 2025-10-28 | $290.18M derived: sum of 2 quarters · filed 2026-08-06 | $441.73M 10-Q · filed 2025-10-28 | $577.87M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $150.09M 10-Q · filed 2026-08-06 | $301.65M 10-Q · filed 2026-08-06 | $437.79M derived: sum of 3 quarters · filed 2026-08-06 | $626.24M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $151.56M 10-Q · filed 2026-05-05 | $287.70M derived: sum of 2 quarters · filed 2026-05-05 | $476.15M derived: sum of 3 quarters · filed 2026-05-05 | $606.61M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $136.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $324.60M derived: sum of 2 quarters · filed 2026-02-26 | $455.06M derived: sum of 3 quarters · filed 2026-02-26 | $580.24M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $188.46M 10-Q · filed 2025-10-28 | $318.92M derived: sum of 2 quarters · filed 2025-10-28 | $444.10M 10-Q · filed 2025-10-28 | $582.03M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $130.46M 10-Q · filed 2025-08-05 | $255.64M 10-Q · filed 2025-08-05 | $393.57M derived: sum of 3 quarters · filed 2026-02-26 | $521.61M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $125.18M 10-Q · filed 2025-05-02 | $263.11M derived: sum of 2 quarters · filed 2026-02-26 | $391.15M derived: sum of 3 quarters · filed 2026-02-26 | $521.77M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $137.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $265.97M derived: sum of 2 quarters · filed 2026-02-26 | $396.59M derived: sum of 3 quarters · filed 2026-02-26 | $532.06M 10-K · filed 2026-02-26 | $514.85M 10-K · filed 2024-02-26 | |||
| 2023-09-30 | $128.04M 10-Q · filed 2024-10-31 | $124.75M 10-Q · filed 2023-11-02 | $258.66M derived: sum of 2 quarters · filed 2024-10-31 | $394.13M 10-Q · filed 2024-10-31 | $379.38M 10-Q · filed 2023-11-02 | $540.78M derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-06-30 | $130.62M 10-Q · filed 2024-08-05 | $128.08M 10-Q · filed 2023-08-02 | $266.09M 10-Q · filed 2024-08-05 | $254.63M 10-Q · filed 2023-08-02 | $412.74M derived: sum of 3 quarters · filed 2025-02-24 | $529.02M derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-03-31 | $135.47M 10-Q · filed 2024-04-26 | $126.55M 10-Q · filed 2023-04-28 | $282.12M derived: sum of 2 quarters · filed 2025-02-24 | $398.40M derived: sum of 3 quarters · filed 2025-02-24 | $521.53M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-12-31 | $146.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $262.93M derived: sum of 2 quarters · filed 2025-02-24 | $386.06M derived: sum of 3 quarters · filed 2025-02-24 | $503.02M 10-K · filed 2025-02-24 | $483.67M 10-K · filed 2023-02-27 | |||
| 2022-09-30 | $116.29M 10-Q · filed 2023-11-02 | $239.41M derived: sum of 2 quarters · filed 2023-11-02 | $356.38M 10-Q · filed 2023-11-02 | $476.13M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $123.13M 10-Q · filed 2023-08-02 | $240.09M 10-Q · filed 2023-08-02 | $359.84M derived: sum of 3 quarters · filed 2024-02-26 | $463.38M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $116.97M 10-Q · filed 2023-04-28 | $236.72M derived: sum of 2 quarters · filed 2024-02-26 | $340.25M derived: sum of 3 quarters · filed 2024-02-26 | $467.31M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $119.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $223.29M derived: sum of 2 quarters · filed 2024-02-26 | $350.35M derived: sum of 3 quarters · filed 2024-02-26 | $470.51M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $103.54M 10-Q · filed 2022-10-28 | $230.60M derived: sum of 2 quarters · filed 2022-10-28 | $350.76M 10-Q · filed 2022-10-28 | $476.90M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $127.06M 10-Q · filed 2022-08-04 | $247.23M 10-Q · filed 2022-08-04 | $373.37M derived: sum of 3 quarters · filed 2023-02-27 | $562.16M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $120.17M 10-Q · filed 2022-04-29 | $246.30M derived: sum of 2 quarters · filed 2023-02-27 | $435.10M derived: sum of 3 quarters · filed 2023-02-27 | $533.06M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $126.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $314.93M derived: sum of 2 quarters · filed 2023-02-27 | $412.90M derived: sum of 3 quarters · filed 2023-02-27 | $524.27M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $188.79M 10-Q · filed 2021-10-29 | $286.76M derived: sum of 2 quarters · filed 2021-10-29 | $398.13M 10-Q · filed 2021-10-29 | $494.03M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $97.97M 10-Q · filed 2021-07-30 | $209.34M 10-Q · filed 2021-07-30 | $305.24M derived: sum of 3 quarters · filed 2022-02-25 | $402.19M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $111.37M 10-Q · filed 2021-04-30 | $207.27M derived: sum of 2 quarters · filed 2022-02-25 | $304.22M derived: sum of 3 quarters · filed 2022-02-25 | $381.66M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $95.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $192.85M derived: sum of 2 quarters · filed 2022-02-25 | $270.28M derived: sum of 3 quarters · filed 2022-02-25 | $359.47M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $96.95M 10-Q · filed 2020-11-06 | $174.38M derived: sum of 2 quarters · filed 2020-11-06 | $263.57M 10-Q · filed 2020-11-06 | $338.59M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $77.44M 10-Q · filed 2020-08-05 | $166.62M 10-Q · filed 2020-08-05 | $241.64M derived: sum of 3 quarters · filed 2021-02-26 | $320.53M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $89.18M 10-Q · filed 2020-05-01 | $164.20M derived: sum of 2 quarters · filed 2021-02-26 | $243.09M derived: sum of 3 quarters · filed 2021-02-26 | $322.11M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $75.02M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $153.91M derived: sum of 2 quarters · filed 2021-02-26 | $232.93M derived: sum of 3 quarters · filed 2021-02-26 | $315.26M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $78.89M 10-Q/A · filed 2019-11-04 | $157.91M derived: sum of 2 quarters · filed 2019-11-04 | $240.25M 10-Q/A · filed 2019-11-04 | $316.24M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $79.02M 10-Q · filed 2019-08-02 | $161.35M 10-Q · filed 2019-08-02 | $237.35M derived: sum of 3 quarters · filed 2020-02-27 | $296.83M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $82.33M 10-Q · filed 2019-04-29 | $158.33M derived: sum of 2 quarters · filed 2020-02-27 | $217.81M derived: sum of 3 quarters · filed 2020-02-27 | $274.11M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $76.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $135.47M derived: sum of 2 quarters · filed 2020-02-27 | $191.78M derived: sum of 3 quarters · filed 2020-02-27 | $241.79M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $59.48M 10-Q · filed 2018-10-26 | $115.78M derived: sum of 2 quarters · filed 2018-10-26 | $165.79M 10-Q · filed 2018-10-26 | $229.94M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $56.30M 10-Q · filed 2018-08-03 | $106.31M 10-Q · filed 2018-08-03 | $170.46M derived: sum of 3 quarters · filed 2019-02-28 | $221.20M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $50.01M 10-Q · filed 2018-04-27 | $114.15M derived: sum of 2 quarters · filed 2019-02-28 | $164.89M derived: sum of 3 quarters · filed 2019-02-28 | $216.51M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $64.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $114.89M derived: sum of 2 quarters · filed 2019-02-28 | $166.50M derived: sum of 3 quarters · filed 2019-02-28 | $209.62M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $50.74M 10-Q · filed 2017-10-31 | $102.36M derived: sum of 2 quarters · filed 2017-10-31 | $145.47M 10-Q · filed 2017-10-31 | $193.52M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $51.62M 10-Q · filed 2017-08-02 | $94.73M 10-Q · filed 2017-08-02 | $142.78M derived: sum of 3 quarters · filed 2018-02-26 | $177.68M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $43.12M 10-Q · filed 2017-05-04 | $91.16M derived: sum of 2 quarters · filed 2018-02-26 | $126.06M derived: sum of 3 quarters · filed 2018-02-26 | $164.13M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $48.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $82.95M derived: sum of 2 quarters · filed 2018-02-26 | $121.01M derived: sum of 3 quarters · filed 2018-02-26 | $152.01M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $34.90M 10-Q · filed 2016-11-03 | $36.72M 10-Q · filed 2015-11-02 | $72.97M derived: sum of 2 quarters · filed 2016-11-03 | $103.97M 10-Q · filed 2016-11-03 | $109.41M 10-Q · filed 2015-11-02 | $142.29M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-06-30 | $38.06M 10-Q · filed 2016-08-08 | $39.88M 10-Q · filed 2015-08-05 | $69.06M 10-Q · filed 2016-08-08 | $72.69M 10-Q · filed 2015-08-05 | $107.38M derived: sum of 3 quarters · filed 2017-02-27 | $137.30M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-03-31 | $31.00M 10-Q · filed 2016-05-02 | $32.81M 10-Q · filed 2015-05-05 | $69.32M derived: sum of 2 quarters · filed 2017-02-27 | $99.24M derived: sum of 3 quarters · filed 2017-02-27 | $130.45M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-31 | $38.32M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $68.24M derived: sum of 2 quarters · filed 2017-02-27 | $99.45M derived: sum of 3 quarters · filed 2017-02-27 | $122.27M 10-K · filed 2017-02-27 | $129.76M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | $29.92M 10-Q · filed 2015-11-02 | $61.13M derived: sum of 2 quarters · filed 2015-11-02 | $83.95M 10-Q · filed 2015-11-02 | $101.22M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $31.21M 10-Q · filed 2015-08-05 | $54.03M 10-Q · filed 2015-08-05 | $71.30M derived: sum of 3 quarters · filed 2016-02-29 | $99.35M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $22.82M 10-Q · filed 2015-05-05 | $40.09M derived: sum of 2 quarters · filed 2016-02-29 | $68.14M derived: sum of 3 quarters · filed 2016-02-29 | $90.71M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $17.27M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $45.32M derived: sum of 2 quarters · filed 2016-02-29 | $67.89M derived: sum of 3 quarters · filed 2016-02-29 | $88.39M 10-K · filed 2016-02-29 | $95.74M 10-K · filed 2014-02-26 | |||
| 2013-09-30 | $28.05M 10-Q · filed 2014-10-28 | $50.62M derived: sum of 2 quarters · filed 2014-10-28 | $71.12M 10-Q · filed 2014-10-28 | $97.65M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $22.57M 10-Q · filed 2014-07-31 | $43.07M 10-Q · filed 2014-07-31 | $69.60M derived: sum of 3 quarters · filed 2015-03-02 | $94.22M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $20.50M 10-Q · filed 2014-05-02 | $47.03M derived: sum of 2 quarters · filed 2015-03-02 | $71.65M derived: sum of 3 quarters · filed 2015-03-02 | $95.22M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $26.53M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $51.15M derived: sum of 2 quarters · filed 2015-03-02 | $74.72M derived: sum of 3 quarters · filed 2015-03-02 | $91.83M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $24.62M 10-Q · filed 2013-10-28 | $48.19M derived: sum of 2 quarters · filed 2013-10-28 | $65.30M 10-Q · filed 2013-10-28 | $86.82M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | $23.57M 10-Q · filed 2013-07-29 | $40.68M 10-Q · filed 2013-07-29 | $62.20M derived: sum of 3 quarters · filed 2014-02-26 | $84.64M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | $17.11M 10-Q · filed 2013-04-29 | $38.62M derived: sum of 2 quarters · filed 2014-02-26 | $61.07M derived: sum of 3 quarters · filed 2014-02-26 | $80.33M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | $21.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $43.96M derived: sum of 2 quarters · filed 2014-02-26 | $63.23M derived: sum of 3 quarters · filed 2014-02-26 | $84.02M 10-K · filed 2014-02-26 | ||||
| 2011-09-30 | $22.45M 10-Q · filed 2012-10-29 | $41.71M derived: sum of 2 quarters · filed 2012-10-29 | $62.50M 10-Q · filed 2012-10-29 | $82.97M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $19.26M 10-Q · filed 2012-08-02 | $40.06M 10-Q · filed 2012-08-02 | $60.53M derived: sum of 3 quarters · filed 2013-02-26 | $78.53M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $20.80M 10-Q · filed 2012-04-30 | $41.27M derived: sum of 2 quarters · filed 2013-02-26 | $59.27M derived: sum of 3 quarters · filed 2013-02-26 | $73.67M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $20.47M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $38.47M derived: sum of 2 quarters · filed 2013-02-26 | $52.87M derived: sum of 3 quarters · filed 2013-02-26 | $70.28M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $18.00M 10-Q · filed 2011-10-31 | $32.40M derived: sum of 2 quarters · filed 2011-10-31 | $49.82M 10-Q · filed 2011-10-31 | $66.55M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $14.40M 10-Q · filed 2011-08-01 | $31.81M 10-Q · filed 2011-08-01 | $48.54M derived: sum of 3 quarters · filed 2012-02-22 | $63.51M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $17.41M 10-Q · filed 2011-04-29 | $34.14M derived: sum of 2 quarters · filed 2012-02-22 | $49.11M derived: sum of 3 quarters · filed 2012-02-22 | $68.96M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $16.73M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $31.70M derived: sum of 2 quarters · filed 2012-02-22 | $51.55M derived: sum of 3 quarters · filed 2012-02-22 | $65.91M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $14.97M 10-Q · filed 2010-10-29 | $34.82M derived: sum of 2 quarters · filed 2010-10-29 | $49.18M 10-Q · filed 2010-10-29 | |||||
| 2009-06-30 | $19.85M 10-Q · filed 2010-08-04 | $34.21M 10-Q · filed 2010-08-04 | ||||||
| 2008-12-31 | $52.51M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |